Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Flu shots and COVID-19 immunity

A new paper finds that the influenza vaccine may influence both the response to and incidence of infection by the SARS-CoV-2.

14 Sep 2021

Prior symptomatic COVID-19 enhances mRNA vaccine response

A new paper describes the antibody responses in people who have already been infected with SARS-CoV-2 and are vaccinated as compared to the naïve.

14 Sep 2021

mRNA BNT162b2 vaccine safe in immunocompromised patients

The clinical trial showed that about 72.2% of immunocompromised patients had detectable antibodies against SARS-CoV-2.

14 Sep 2021

Convalescent plasma shows no benefit in hospitalized COVID-19 patients

A new paper describes the results of a randomized controlled trial of CP in adult COVID-19 patients on oxygen when used within 12 days of the onset of respiratory symptoms.

14 Sep 2021

How effective are COVID-19 vaccines against mild and severe disease?

A new paper in the New England Journal of Medicine reports on the effectiveness of the COVID-19 vaccines in a healthcare setting.

14 Sep 2021

Effectiveness of mRNA-1273 against asymptomatic infection, COVID-19 diagnosis, and severe outcomes

A Moderna phase 3 trial provides evidence that the RNA-1273 vaccine is highly effective in preventing disease following infection SARS-CoV-2.

14 Sep 2021

Impact of prior SARS-CoV-2 infection and vaccine on antibody levels: Texas survey

A collaborative team, led by principal investigator Dr. Eric Boerwinkle, at The University of Texas Health Science Center at Houston, School of Public Health is conducting a survey designed to assess the frequency of antibody-positive individuals across Texas. The TEXAS Coronavirus Antibody REsponse Survey (CARES) aims to look for antibodies in the blood made in response to natural SARS-CoV-2 infection or vaccination.

14 Sep 2021

Gorillas at Atlanta Zoo have been infected by SARS-CoV-2

At Zoo Atlanta, 18 western lowland gorillas are currently receiving treatment for COVID-19 as initial and tests came back positive.

14 Sep 2021

SARS-CoV-2 infections surged in England this summer, despite high vaccine uptake

Researchers in the UK have warned that England experienced a rapid exponential increase this summer in the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – despite high rates of vaccination uptake.

14 Sep 2021

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Researchers in the UK have conducted a large population-based study showing that people with immune-mediated inflammatory diseases (IMIDs) appear to be at an increased risk of serious outcomes from coronavirus disease 2019 (COVID-19).

14 Sep 2021

Digital spatial profiling of individual glomeruli from HIV and COVID-19 patients

Now, a new study posted to the bioRxiv* server by scientists from the University of Washington explores the use of NanoString’s GeoMx digital spatial profiling (DSP) to investigate CG caused by HIV and SARS-Cov-2 infections.

14 Sep 2021

Metabolic and immune markers as tools for risk stratification and monitoring in COVID-19

In a new study posted to the medRxiv* server scientists from Weil Cornell University and Stony Brook University in New York attempted to identify the metabolic and immune markers associated with severe COVID-19 disease using high-throughput targeted nuclear magnetic resonance (NMR) spectroscopy and high-dimensional flow cytometry. This will facilitate risk stratification, monitoring, and therapeutic interventions in COVID-19 patients.

14 Sep 2021

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Flu shots and COVID-19 immunity

Prior symptomatic COVID-19 enhances mRNA vaccine response

mRNA BNT162b2 vaccine safe in immunocompromised patients

Convalescent plasma shows no benefit in hospitalized COVID-19 patients

How effective are COVID-19 vaccines against mild and severe disease?

Effectiveness of mRNA-1273 against asymptomatic infection, COVID-19 diagnosis, and severe outcomes

Impact of prior SARS-CoV-2 infection and vaccine on antibody levels: Texas survey

Gorillas at Atlanta Zoo have been infected by SARS-CoV-2

SARS-CoV-2 infections surged in England this summer, despite high vaccine uptake

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Digital spatial profiling of individual glomeruli from HIV and COVID-19 patients

Metabolic and immune markers as tools for risk stratification and monitoring in COVID-19

Dynamics of healthcare-associated SARS-CoV-2 infections revealed with whole genome sequencing

COVID-19 lockdown linked to improved glycemic control in type 1 diabetes

Guidelines: Summer camp returns to normal during COVID-19

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Study identifies broadly neutralizing antibody panel against SARS-like viruses

New SARS-CoV-2 mechanism of host gene suppression

Efficient non-neutralizing antibody to SARS-CoV-2 spike NTD that operates via Fc receptor-mediated pathway

Age-related differences in immune dynamics in rhesus macaques infected with SARS-CoV-2

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in